ID

29696

Description

An Exploratory Study of Telaprevir in Treatment-Naive Participants With Chronic Genotype 4 Hepatitis C Virus Infection; ODM derived from: https://clinicaltrials.gov/show/NCT00580801

Lien

https://clinicaltrials.gov/show/NCT00580801

Mots-clés

Versions (1)
  1. 13/04/2018 13/04/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

13 avril 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Hepatitis C NCT00580801

Anglais

Eligibility Hepatitis C NCT00580801

1 Formulaires  
Criteria
Description

Criteria

plasma hepatitis c virus (hcv) ribonucleic acid (rna) level greater than 10,000 international unit per milliliter (iu/ml) at screening
Description

Plasma Hepatitis C virus RNA IU/mL

Type de données

boolean

Alias
UMLS CUI [1,1]
C0032105
UMLS CUI [1,2]
C0369335
UMLS CUI [1,3]
C0439458
participant never received treatment for hcv
Description

Absence Therapeutic procedure Hepatitis C virus

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0220847
participant was to be in good health (besides hcv infection), in the opinion of the investigator, judged on the basis of medical history and physical examination (including vital signs and screening electrocardiogram [ecg]), with any chronic medical conditions under stable medical control
Description

Good health | Exception Hepatitis C | Medical History | Physical Examination | Vital signs | Electrocardiography | Medical condition chronic Under control

Type de données

boolean

Alias
UMLS CUI [1]
C3813622
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0019196
UMLS CUI [3]
C0262926
UMLS CUI [4]
C0031809
UMLS CUI [5]
C0518766
UMLS CUI [6]
C1623258
UMLS CUI [7,1]
C3843040
UMLS CUI [7,2]
C0205191
UMLS CUI [7,3]
C2911690
participant had to be willing to refrain from the concomitant use of any medications or substances exclusion criteria: - participants with history or evidence of cirrhosis or history of suspicion of alcohol, barbiturate, or amphetamine recreational or narcotic drug use, which in the investigator's opinion would compromise the participant's safety and/or compliance with study procedures
Description

Avoidance Concomitant Agent | Exclusion Criteria | Liver Cirrhosis | Alcohol consumption compromises Patient safety | Barbiturates compromise Patient safety | Amphetamine compromises Patient safety | Narcotic Drugs compromise Patient safety | Alcohol consumption compromises Protocol Compliance | Barbiturates compromise Protocol Compliance | Amphetamine compromises Protocol Compliance | Narcotic Drugs compromise Protocol Compliance

Type de données

boolean

Alias
UMLS CUI [1,1]
C0870186
UMLS CUI [1,2]
C2347852
UMLS CUI [2]
C0680251
UMLS CUI [3]
C0023890
UMLS CUI [4,1]
C0001948
UMLS CUI [4,2]
C2945640
UMLS CUI [4,3]
C1113679
UMLS CUI [5,1]
C0004745
UMLS CUI [5,2]
C2945640
UMLS CUI [5,3]
C1113679
UMLS CUI [6,1]
C0002658
UMLS CUI [6,2]
C2945640
UMLS CUI [6,3]
C1113679
UMLS CUI [7,1]
C0237425
UMLS CUI [7,2]
C2945640
UMLS CUI [7,3]
C1113679
UMLS CUI [8,1]
C0001948
UMLS CUI [8,2]
C2945640
UMLS CUI [8,3]
C0525058
UMLS CUI [9,1]
C0004745
UMLS CUI [9,2]
C2945640
UMLS CUI [9,3]
C0525058
UMLS CUI [10,1]
C0002658
UMLS CUI [10,2]
C2945640
UMLS CUI [10,3]
C0525058
UMLS CUI [11,1]
C0237425
UMLS CUI [11,2]
C2945640
UMLS CUI [11,3]
C0525058
participant has human immunodeficiency virus (hiv) or hepatitis b virus (hbv) co-infection
Description

HIV coinfection | HBV coinfection

Type de données

boolean

Alias
UMLS CUI [1]
C4062778
UMLS CUI [2]
C2242656
female participants who are pregnant, or planning to become pregnant, or breastfeeding, and partners of female participants who are pregnant or breastfeeding
Description

Pregnancy | Pregnancy, Planned | Breast Feeding | Partner Study participant Pregnancy | Partner Study participant Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
UMLS CUI [3]
C0006147
UMLS CUI [4,1]
C0682323
UMLS CUI [4,2]
C0681850
UMLS CUI [4,3]
C0032961
UMLS CUI [5,1]
C0682323
UMLS CUI [5,2]
C0681850
UMLS CUI [5,3]
C0006147
participant has hypersensitivity to tartrazine
Description

Hypersensitivity Tartrazine

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0039329
participant had participated in any clinical trial for an investigational drug within 90 days before drug administration or participated in more than 2 drug studies in the last 12 months
Description

Study Subject Participation Status | Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
Retour au début de la page

Similar models

Eligibility Hepatitis C NCT00580801

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Plasma Hepatitis C virus RNA IU/mL
Item
plasma hepatitis c virus (hcv) ribonucleic acid (rna) level greater than 10,000 international unit per milliliter (iu/ml) at screening
boolean
C0032105 (UMLS CUI [1,1])
C0369335 (UMLS CUI [1,2])
C0439458 (UMLS CUI [1,3])
Absence Therapeutic procedure Hepatitis C virus
Item
participant never received treatment for hcv
boolean
C0332197 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0220847 (UMLS CUI [1,3])
Good health | Exception Hepatitis C | Medical History | Physical Examination | Vital signs | Electrocardiography | Medical condition chronic Under control
Item
participant was to be in good health (besides hcv infection), in the opinion of the investigator, judged on the basis of medical history and physical examination (including vital signs and screening electrocardiogram [ecg]), with any chronic medical conditions under stable medical control
boolean
C3813622 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0019196 (UMLS CUI [2,2])
C0262926 (UMLS CUI [3])
C0031809 (UMLS CUI [4])
C0518766 (UMLS CUI [5])
C1623258 (UMLS CUI [6])
C3843040 (UMLS CUI [7,1])
C0205191 (UMLS CUI [7,2])
C2911690 (UMLS CUI [7,3])
Avoidance Concomitant Agent | Exclusion Criteria | Liver Cirrhosis | Alcohol consumption compromises Patient safety | Barbiturates compromise Patient safety | Amphetamine compromises Patient safety | Narcotic Drugs compromise Patient safety | Alcohol consumption compromises Protocol Compliance | Barbiturates compromise Protocol Compliance | Amphetamine compromises Protocol Compliance | Narcotic Drugs compromise Protocol Compliance
Item
participant had to be willing to refrain from the concomitant use of any medications or substances exclusion criteria: - participants with history or evidence of cirrhosis or history of suspicion of alcohol, barbiturate, or amphetamine recreational or narcotic drug use, which in the investigator's opinion would compromise the participant's safety and/or compliance with study procedures
boolean
C0870186 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C0680251 (UMLS CUI [2])
C0023890 (UMLS CUI [3])
C0001948 (UMLS CUI [4,1])
C2945640 (UMLS CUI [4,2])
C1113679 (UMLS CUI [4,3])
C0004745 (UMLS CUI [5,1])
C2945640 (UMLS CUI [5,2])
C1113679 (UMLS CUI [5,3])
C0002658 (UMLS CUI [6,1])
C2945640 (UMLS CUI [6,2])
C1113679 (UMLS CUI [6,3])
C0237425 (UMLS CUI [7,1])
C2945640 (UMLS CUI [7,2])
C1113679 (UMLS CUI [7,3])
C0001948 (UMLS CUI [8,1])
C2945640 (UMLS CUI [8,2])
C0525058 (UMLS CUI [8,3])
C0004745 (UMLS CUI [9,1])
C2945640 (UMLS CUI [9,2])
C0525058 (UMLS CUI [9,3])
C0002658 (UMLS CUI [10,1])
C2945640 (UMLS CUI [10,2])
C0525058 (UMLS CUI [10,3])
C0237425 (UMLS CUI [11,1])
C2945640 (UMLS CUI [11,2])
C0525058 (UMLS CUI [11,3])
HIV coinfection | HBV coinfection
Item
participant has human immunodeficiency virus (hiv) or hepatitis b virus (hbv) co-infection
boolean
C4062778 (UMLS CUI [1])
C2242656 (UMLS CUI [2])
Pregnancy | Pregnancy, Planned | Breast Feeding | Partner Study participant Pregnancy | Partner Study participant Breast Feeding
Item
female participants who are pregnant, or planning to become pregnant, or breastfeeding, and partners of female participants who are pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0682323 (UMLS CUI [4,1])
C0681850 (UMLS CUI [4,2])
C0032961 (UMLS CUI [4,3])
C0682323 (UMLS CUI [5,1])
C0681850 (UMLS CUI [5,2])
C0006147 (UMLS CUI [5,3])
Hypersensitivity Tartrazine
Item
participant has hypersensitivity to tartrazine
boolean
C0020517 (UMLS CUI [1,1])
C0039329 (UMLS CUI [1,2])
Study Subject Participation Status | Investigational New Drugs
Item
participant had participated in any clinical trial for an investigational drug within 90 days before drug administration or participated in more than 2 drug studies in the last 12 months
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial